Gender Change in 46,XY Persons with 5α-Reductase-2 Deficiency and 17β-Hydroxysteroid Dehydrogenase-3 Deficiency

@article{CohenKettenis2005GenderCI,
  title={Gender Change in 46,XY Persons with 5$\alpha$-Reductase-2 Deficiency and 17$\beta$-Hydroxysteroid Dehydrogenase-3 Deficiency},
  author={P. Cohen-Kettenis},
  journal={Archives of Sexual Behavior},
  year={2005},
  volume={34},
  pages={399-410}
}
Individuals with 5α-reductase-2 deficiency (5α-RD-2) and 17β-hydroxysteroid dehydrogenase-3 deficiency (17β-HSD-3) are often raised as girls. Over the past number of years, this policy has been challenged because many individuals with these conditions develop a male gender identity and make a gender role change after puberty. The findings also raised doubts regarding the hypothesis that children are psychosexually neutral at birth and emphasized the potential role of prenatal brain exposure to… Expand
46,XY disorder of sex development (DSD) due to 17β-hydroxysteroid dehydrogenase type 3 deficiency
TLDR
The proposal in this article is to review the previously reported cases of 17β-HSD3 deficiency adding the authors' own cases and molecular genetic testing confirms the diagnosis and provides the orientation for genetic counseling. Expand
Complexities of gender assignment in 17β-hydroxysteroid dehydrogenase type 3 deficiency: is there a role for early orchiectomy?
TLDR
Although existing data are limited, early orchiectomy is likely to result in retention of female gender identity, avoiding the complications related to virilization in adolescence, and to pursue a definitive diagnosis to guide clinical decisions. Expand
46,XY DSD due to 17β-HSD3 deficiency and 5α-reductase type 2 deficiency.
TLDR
Two variables were significantly associated with the change of male social sex in patients 46,XY female which were registered and non-castrated in childhood: male kids games and self-perceived physical appearance as male or ambiguous during childhood. Expand
Pubertal Development in
17Beta-Hydroxysteroid Dehydrogenase Type 3 Deficiency

TLDR
All 4 patients with 17β-HSD type 3 deficiency synthesized relevant amounts of testosterone at puberty, which lead to variable androgenisation, thereby inducing male pubertal development in patients with presumable residual activity of the mutated enzyme. Expand
Chapter 3K – 46,XY DSD due to 17β-Hydroxysteroid Dehydrogenase 3 Deficiency
TLDR
The proposal in this article is to review the reported and the own cases of 17β-HSD3 deficiency, a defect in the last phase of steroidogenesis that is clinically indistinguishable from other causes of 46,XY DSD such as partial androgen insensitivity syndrome and 5α-reductase 2 deficiency. Expand
Gender identity in patients with 5-alpha reductase deficiency raised as females.
TLDR
Undervirilized patients with a diagnosis of 5-ARD raised as female were in complete conformation with being female and described themselves as heterosexual, with the more virilized Patients were those least in conformity with their female-assigned gender. Expand
Germ cell neoplasia in situ complicating 17β-hydroxysteroid dehydrogenase type 3 deficiency
TLDR
As some individuals with 17βHSD3 deficiency transition from a female sex assignment to identifying as males, providers should ensure stable gender identity prior to recommending irreversible treatments. Expand
The Dilemma of Sex Reassignment in an Adolescent with 17β-HSD-3 Deficiency Raised as a Female: Ten-Year Follow-Up
TLDR
An XY individual with 17b-HSD-3 deficiency raised as female is described, the dilemmas arising at age 17 years when the question of sex reassignment was seriously considered, as well as her follow-up of 10 years post-feminizing surgery of the external genitalia. Expand
Clinical and molecular spectrum of patients with 17β-hydroxysteroid dehydrogenase type 3 (17-β-HSD3) deficiency.
TLDR
Four patients with the 46,XY karyotype and 17-β-HSD3 deficiency are reported, showing different degrees of genital ambiguity, increased androstenedione and decreased testosterone levels, and testosterone to androstensione ratio < 0.8. Expand
5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature
TLDR
The reported cases suggest the possibility to consider a new approach for gender assignment in individuals with SRD5A2 deficiency, involving them directly in the decision-making process and allowing them to explore their gender identity, also with the help of GnRH analogues to delay pubertal modifications. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 66 REFERENCES
Steroid 17β-hydroxysteroid dehydrogenase deficiency in man: An inherited form of male pseudohermaphroditism
  • A. Rösler
  • Medicine, Biology
  • The Journal of Steroid Biochemistry and Molecular Biology
  • 1992
TLDR
Both in vivo and in vitro studies indicate that the severity of testicular 17β-HSD deficiency changes with age, and there is a progressive restoration after puberty. Expand
Steroid 5 alpha-reductase deficiency in a 65-year-old male pseudohermaphrodite: the natural history, ultrastructure of the testes, and evidence for inherited enzyme heterogeneity.
We report a 65-yr-old male pseudohermaphrodite with steroid 5 alpha-reductase deficiency in whom there was no medical intervention before, during, or after puberty, enabling us to observe the naturalExpand
Male Pseudohermaphroditism due to 17&bgr;‐Hydroxysteroid Dehydrogenase 3 Deficiency: Diagnosis, Psychological Evaluation, and Management
TLDR
While androgen action plays a role in the process, additional undefined psychological, social, and/or biologic factors must be determinants of gender identity/role behavior. Expand
Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5alpha-reductase deficiency.
TLDR
Exposure of the brain to normal levels of testosterone in utero, neonatally and at puberty appears to contribute substantially to the formation of male-gender identity, over-riding the effect of rearing as girls. Expand
Male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Diagnosis, psychological evaluation, and management.
TLDR
Sixteen subjects (from 10 Brazilian families) with male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency have been evaluated in 1 clinic, with results indicating limited growth of the prostate and penis and increase in body and facial hair and enhancement of libido and sexual performance. Expand
Diagnosis of 5α-Reductase Deficiency in a Teenage Turkish Girl
TLDR
A Turkish patient clinically classified with steroid 5α-reductase deficiency (SRD) type 3b (karyotype 46, XY) who was raised as a girl and presented to us at the age of 14 years because the male phenotype had become predominant at puberty is reported. Expand
Prepubertal Diagnosis of Steroid 5α-Reductase Deficiency
The diagnosis of 5α-reductase deficiency was proven in two prepubertal patients with male pseudohermaphroditism (MPH). Both had a 46-XY karyotype and were reared as females; one child had beenExpand
Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency.
TLDR
It is suggested that the common mechanism for testosterone formation in postpubertal subjects with this disorder is the conversion of circulating androstenedione to testosterone by one or more of the unaffected 17 beta-hydroxysteroid dehydrogenase isoenzymes. Expand
Clinical, endocrinological, and enzymatic characterization of two patients with 5 alpha-reductase deficiency: evidence that a single enzyme is responsible for the 5 alpha-reduction of cortisol and testosterone.
TLDR
Two siblings with 46,XY male pseudohermapthroditism were demonstrated to have the phenotype characteristic of 5 alpha-reductase deficiency, namely normal testes and male Wolffian duct derivatives terminating in a blind-ending vagina, and studies of control and mutant epididymal microsomes indicated that a single enzyme is responsible in the normal person for the 5alpha-reduction of testosterone and cortisol. Expand
Male pseudohermaphroditism secondary to 17 beta-hydroxysteroid dehydrogenase deficiency: gender role change with puberty.
TLDR
A 31-yr-old male pseudohermaphrodite is reported with 17 beta-hydroxysteroid dehydrogenase deficiency and an abnormal androstenedione to testosterone ratio. Expand
...
1
2
3
4
5
...